Indegene
Indegene acquires BioPharm to advance AI-driven life sciences marketing
The acquisition strengthens Indegene’s AI-enabled commercialisation and AdTech capabilities
Indegene announces acquisition of Trilogy Writing & Consulting
The deal is aimed at increasing Indegene’s clinical and regulatory writing expertise for global market authorisation applications
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott
Indegene Pharma Marketer 2020 Report predicts significant shift in channel spends
Content personalisation to continue to yield disproportionate returns
Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications
by Marc Valdiviezo
The bulk of pharma digital spend fails to alter industry’s greenhorn status
Indegene’s Digital Maturity study reveals huge gaps in KPIs
OPEN Health acquires Choice Healthcare Solutions
Will rebrand the agency under its Succinct agency offering
Deal Watch March 2016
AstraZeneca, Roche, Sanofi and Valeant are featured in this month’s roundup of pharma deals
Sanofi hints at sweetened Medivation deal – or hostile bid
CEO Oliver Brandicourt claims “overwhelming support” for deal from shareholders
Medivation unimpressed with Sanofi’s offer
CEO says the offer “substantially undervalues” the oncology specialist